.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Covington
Moodys
US Department of Justice
Dow
AstraZeneca
Cerilliant
Mallinckrodt
Johnson and Johnson
Deloitte

Generated: June 29, 2017

DrugPatentWatch Database Preview

TRIACET Drug Profile

« Back to Dashboard

Which patents cover Triacet, and when can generic versions of Triacet launch?

Triacet is a drug marketed by Teva and is included in one NDA.

The generic ingredient in TRIACET is triamcinolone acetonide. There are fifty drug master file entries for this compound. Eighty-two suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.

Summary for Tradename: TRIACET

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list60
Patent Applications: see list6,410
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TRIACET at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva
TRIACET
triamcinolone acetonide
CREAM;TOPICAL084908-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Teva
TRIACET
triamcinolone acetonide
CREAM;TOPICAL084908-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Teva
TRIACET
triamcinolone acetonide
CREAM;TOPICAL084908-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Chinese Patent Office
Federal Trade Commission
QuintilesIMS
Queensland Health
Argus Health
Accenture
Merck
Novartis
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot